Show simple item record

dc.contributor.authorManguyu, F W
dc.date.accessioned2019-09-12T06:31:38Z
dc.date.available2019-09-12T06:31:38Z
dc.date.issued1982
dc.identifier.urihttp://erepository.uonbi.ac.ke/handle/11295/107109
dc.description.abstractThis is a prospective study of eighteen cni Idr-e n with kala azar (Visceral- Le ishmanias is) seen at the Kenyatta National Hospital~ Nairobi. The clinical and haematological data before and for each week during treatment is presented and discussed. Sixteen patients were given the standard dose of pentostam. The treatment was continued daily without interruption until the patients were parasitologically_ negative on splenic aspirates. Only one out of these sixteen patients failed to respond after twelve weeks of pentostam. Two patients known to be resistant to pentostam were treated with a combination of pentostam and allopurinol. From this study~ it is apparent that patients respond differently to treatment with pentostam. The duration of treatment ranged from four to eleven weeks. Each case of kala azar should therefore be viewed on its own merits as far as duration of treatment is concerned ~. Complete .cur e can only be determined with time~ it is recommended that patients should I be closely followed up after discharge from hospital.en_US
dc.language.isoenen_US
dc.publisherUniversity of Nairobien_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subjectThe Clinical and Haematological Response to Treatment in Children With Kala Azar.en_US
dc.titleThe Clinical and Haematological Response to Treatment in Children With Kala Azar.en_US
dc.typeThesisen_US
dc.description.departmenta Department of Psychiatry, University of Nairobi, ; bDepartment of Mental Health, School of Medicine, Moi University, Eldoret, Kenya


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States